-
Panthera opens for clinical trials in Manchester, its second clinical trial site in the UK, with additional health and safety precautions to protect staff and patients from COVID-19.
Apr 19, 2020
-
Apr 19, 2020
-
Apr 22, 2020
-
GattaCo Inc. is developing next generation products and technologies in sample preparation for point-of-need in-vitro diagnostic testing and research applications. These products and technologies enable the decentralization of complex diagnostic testing and help solve global healthcare challenges. With the A-PON™, GattaCo is tackling unmet needs in sample preparation to streamline and improve diagnostic testing of the SARS-CoV-2 virus to help eradicate COVID-19 disease.
Apr 23, 2020
-
Apr 26, 2020
-
Apr 26, 2020
-
Located on the Tufts University Medford, MA campus, this new donor center will enable delivery of fresh blood, leukopaks and buffy coats for COVID-19, cell and gene therapy research within hours of collection.
Apr 5, 2020
-
VERICHEM LABORATORIES is pleased to announce the availability of their ready-to-use, liquid stable ENZYME ER™ Verifier Kit, expressly designed for the calibration verification of enzyme assays on any “wet” clinical testing system.
Apr 5, 2020
-
Independent Site Management Organisation Panthera is working with sponsors who need to press ahead with trials which can be done safely.
Apr 5, 2020
-
Apr 2, 2020
-
Scopio Labs Receives CE Mark for X100 Microscope and Decision Support System With Full Field Peripheral Blood Smear (PBS) Application
Apr 12, 2020
-
A newly validated app called Rafi-Tone, developed by clinicians in the UK, makes using an inhaler with a spacer easier and more fun for young children with wheeze or asthma symptoms.
Apr 13, 2020
-
BSC is collecting blood samples from sick and recovered COVID-19 patients to assist in developing COVID-19 therapies, vaccines and diagnostic biomarkers.
Apr 14, 2020
-
Apr 14, 2020
-
Fluxergy LLC has filed an Emergency Use Authorization (EUA) request for FDA authorization of the company's high-speech COVID-19 diagnostic test, which has been shown to provide sample-to-answer data within one hour at the point-of-care.
Mar 29, 2020
-
CD Bioparticles introduces carbon-based nanocages production services to global researchers.
Mar 29, 2020
-
Apr 1, 2020
-
The FDA has provided Emergency Use Authorization for a new 24-hour, Saliva Test for COVID-19, available now to clinics, hospitals and patients. This will alleviate resource shortages (swabs and transport) hindering other testing methods. MicroGenDX is ramping up capacity for 10,000 tests/day with a turnaround time of 24 hours.
Apr 2, 2020
-
Mar 25, 2020
-
Mar 25, 2020